Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Scilex Pharmaceuticals, Inc.
Scilex Pharmaceuticals, Inc.
Industry · 13 registered clinical trials.
Status
Trial
Phase
Started
Completed
Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain
Moderate to Severe Acute Lower Back Pain
Phase 2
2022-04-29
Completed
Pharmacokinetics of SP-104
Healthy
Phase 1
2022-01-11
Completed
Study to Evaluate the Safety of SP-104
Healthy Volunteers
Phase 1
2021-10-04
Completed
Clinical Adhesion Study Between ZTlido 1.8% and Three Over-the-counter External Analgesic Lidocaine-containing
Healthy
Phase 1
2021-07-01
Completed
Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% With Water Exposure
Healthy
Phase 1
2019-08-21
Completed
Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects
Healthy
Phase 1
2019-08-03
Completed
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Generic Lidocaine Patch 5% in Healthy,
Healthy
Phase 1
2018-09-07
Completed
Corticosteroid Lumbar Epidural Analgesia for Radiculopathy
Lumbosacral Radicular Pain
Phase 3
2017-12-08
Completed
Adhesion Performance Study of Lidocaine Topical System 1.8% Compared to Lidocaine Patch 5% and Lidocaine Medic
Healthy
Phase 1
2017-02-14
Completed
Comparative Pharmacokinetic Study of Lidocaine Patch 1.8% (ZTlido™) and Lidocaine Patch 5% (Lidoderm®) in Heal
Healthy
Phase 1
2016-09-28
Completed
Pharmacokinetics and Adhesion of Lidocaine Topical System 1.8% Under Conditions of Heat and Exercise
Healthy
Phase 1
2016-01-08
Completed
Adhesion of Lidocaine Topical System 1.8%
Healthy
Phase 1
2015-12-01
Completed
Pharmacokinetic Study of Lidocaine Patch 1.8% Lidocaine Patch 5% (Lidoderm®) in Healthy Subjects
Healthy
Phase 1
2014-04-28